2018

Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2018, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.

2017 update to the HIV-TRePS system: The development of new computational models to predict HIV treatment outcomes, with or without a genotype with enhanced usability for low-income settings
Revell AD, Wang D, Perez-Elias M-J,Wood R Cogill D, Tempelman H,Hamers RL, Reiss P, van Sighem A, Rehm CA, Pozniak A, Montaner JSG, Lane HC & Larder BA on behalf of the RDI study group.
Journal of Antimicrobial Chemotherapy Abstract

Associations between serum albumin and serious non-AIDS events among people living with HIV
Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P, Weber R, Pradier C, De Wit S, Law M, Monforte AD, Lundgren J, Mocroft A, Phillips AN, Sabin CA; D:A:D Study group.
AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001900. [Epub ahead of print] Abstract

Easy and accurate reconstruction of whole HIV genomes from short-read sequence data
Wymant C, Blanquart F, Golubchik T, Gall A, Bakker M, Bezemer D, Croucher NJ, Hall M, Hillebregt M, Ong SH, Ratmann O, Albert J, Bannert N, Fellay J, Fransen K, Gourlay A, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Cornelissen M, Kellam P, Reiss P, Fraser C; BEEHIVE Collaboration.
Virus Evol. 2018 May 18;4(1):vey007. doi: 10.1093/ve/vey007. eCollection 2018 Jan. Abstract

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4:CD8 ratio: ART Cohort Collaboration (ART-CC) Study
Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, Monforte AD, Smith C, Cavassini M, Saag M, Sterling TR, Sterne JAC.
AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001848. [Epub ahead of print] Abstract

Body mass index and the risk of serious non-AIDS events and all cause mortality in treated HIV-positive individuals: D: A: D cohort analysis
Achhra AC, Sabin C, Ryom L, Hatleberg C, d'Aminio Monforte A, Wit S, Phillips A, Pradier C, Weber R, Reiss P, El-Sadr W, Bonnet F, Mocroft A, Lundgren J, Law MG; D:A:D study group.
J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097 Abstract

The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics
De Francesco D, Wit FW, Cole JH, Kootstra NA, Winston A, Sabin CA, Underwood J, van Zoest RA, Schouten J, Kooij KW, Prins M, Guaraldi G, Caan MWA, Burger D, Franceschi C, Libert C, Bürkle A, Reiss P; COmorBidity in Relation to AIDS (COBRA) collaboration.
PLoS One. 2018 Mar 29;13(3):e0191791. doi: 10.1371/journal.pone.0191791. eCollection 2018 Abstract

HIV-1 status is independently associated with decreased erectile function among middle-aged men who have sex with men in the era of cART
Dijkstra M, Van Lunsen RHW, Kooij KW, Davidovich U, Van Zoest RA, Wit FWMN, Prins M, Reiss P, Loeff MFSV; AGEhIV Cohort Study Group.
AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001800. [Epub ahead of print] Abstract

The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people
Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.
HIV Med. 2018 Feb;19(2):90-101. doi: 10.1111/hiv.12546. Epub 2017 Aug 31. Abstract

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens
Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group.
HIV Med. 2018 Feb;19(2):102-117. doi: 10.1111/hiv.12557. Epub 2017 Oct 6. Abstract

Abacavir use and risk of recurrent myocardial infarction
Sabin CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, Pradier C, El-Sadr W, Kirk O, Weber R, Phillips AN, Mocroft A, Bonnet F, Law M, de Wit S, Reiss P, Lundgren JD; D:A:D Study Group.
AIDS. 2018 Jan 2;32(1):79-88. doi: 10.1097/QAD.0000000000001666. Abstract

Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection
Young J, Smith C, Teira R, Reiss P, Jarrín Vera I, Crane H, Miro JM, D'Arminio Monforte A, Saag M, Zangerle R, Bucher HC; Antiretroviral Therapy Cohort Collaboration (ART-CC).
HIV Med. 2018 Feb;19(2):132-142. doi: 10.1111/hiv.12562. Epub 2017 Nov 6. Abstract

Global trends in CD4 count at start of antiretroviral treatment: collaborative study of treatment programs
IeDEA and COHERE Cohort Collaborations
Clin Infect Dis. 2018 Jan 25. doi: 10.1093/cid/cix915. [Epub ahead of print] Abstract

Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age
Snijdewind IJM, Smit C, Godfried MH, Bakker R, Nellen JFJB, Jaddoe VWV, van Leeuwen E, Reiss P, Steegers EAP, van der Ende ME.
PLoS One. 2018 Jan 19;13(1):e0191389. doi: 10.1371/journal.pone.0191389. eCollection 2018. Abstract

Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K; for CASCADE Collaboration in EuroCoord.
AIDS. 2018 Jan 14;32(2):161-169. doi: 10.1097/QAD.0000000000001689. Abstract

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD; EuroSIDA Study.
AIDS. 2018 Jan 14;32(2):205-215. doi: 10.1097/QAD.0000000000001684. Abstract

No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project.
Cole JH, Caan MWA, Underwood J, De Francesco D, van Zoest RA, Wit FWNM, Mutsaerts HJMM, Leech R, Geurtsen GJ, Portegies P, Majoie CBLM, Schim van der Loeff MF, Sabin CA, Reiss P, Winston A, Sharp DJ; COBRA collaboration.
Clin Infect Dis. 2018 Jan 4. doi: 10.1093/cid/cix1124. [Epub ahead of print] Abstract

Increased non-AIDS mortality among persons with AIDS defining events after antiretroviral therapy initiation
Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JAC, Sterling TR, for the Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators
J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031. Abstract

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases.
Engelhard EAN, Smit C, van Dijk PR, Kuijper TM, Wermeling PR, Weel AE, de Boer MR, Brinkman K, Geerlings SE, Nieuwkerk PT.
AIDS. 2018 Jan 2;32(1):103-112. doi: 10.1097/QAD.0000000000001672. Abstract

Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions
Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, Gill J, Vandenhende MA, Barger D, Lodi S, Moreno S, Arribas JR, Pacheco A, Cardoso SW, Chrysos G, Gogos C, Abgrall S, Costagliola D, Meyer L, Seng R, van Sighem A, Reiss P, Muga R, Hoyos SP, Braun D, Hauser C, Barrufet P, Leyes M, Tate J, Justice A, Hernán MA.
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):102-109. doi: 10.1097/QAI.0000000000001562. Abstract

 
 

Stichting HIV Monitoring

Stichting HIV Monitoring (SHM) levert een belangrijke en noodzakelijke bijdrage aan de zorg voor mensen met hiv in Nederland. Door middel van het verzamelen en bewerken van gecodeerde data van hiv-positieve personen uit het hele land draagt ons monitor-onderzoek structureel bij aan de kennis over hiv en stelt het behandelend artsen in staat om de zorg voor hun patiënten continu te verbeteren. Ons jaarlijkse Monitoring Report geeft waardevolle input voor het ontwikkelen van hiv-zorg en preventiebeleid in Nederland en binnen de Europese Unie.

Bezoekadres

Nicolaes Tulphuis
Tafelbergweg 51
1105 BD Amsterdam

Postadres

Academisch Medisch Centrum
Universiteit van Amsterdam
Meibergdreef 9 1105 AZ Amsterdam

© Stichting HIV Monitoring  | Disclaimer  | Colofon